🔗 Share this article

An underground market for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Investigational Drug Gaining Traction Online

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Followers are urged to contact these profiles directly for supplier links, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a robust trade exists on Telegram, where communities with numerous of participants share comparison photos, injection guides and assertions of next-day UK delivery. Vendors market the drug there before redirecting buyers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Medical Professionals Voice Worries

However, doctors and chemists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in users administering products of unknown origin.

Some experts said the demand for retatrutide could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for human use under the British medical regulations.

Several influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach medicines, marketing, and consumer laws, risking fines, legal action or prison.

Service Response and Content Elimination

According to TikTok, the platform has removed problematic content and banned related keywords and search suggestions. The company said it was committed to keeping the platform secure and allocating resources in strengthening compliance measures.

Digital Trading Operations

Research also discovered groups with up to nine thousand members marketing the experimental drug using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately brings up channels with thousands of users, populated with photos of weight loss, glowing testimonials and detailed guides for mixing or injecting at home.

After moments of joining one community, a vendor shared WhatsApp details, where most transactions take place. The seller provided an guidebook and guaranteed delivery within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about body mass, medical conditions or previous experience.

Product Details and Costs

Within these groups, posts display dark colored packages with postal service labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with sterile water, or ready-to-use pens usually priced at £160 for 20mg. When asked how long a pen should last, sellers give contradictory responses varying between a several days to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for the messaging service said it regularly monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting substances they can’t verify. Even if the research behind retatrutide is valid, these online versions may not contain what they claim,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in interest to recent price rises for authorized slimming medications such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.

Her team has previously encountered patients harmed by personal administration from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly investigational substance not yet approved … may expose users to potentially serious health risks”.